Novo Nordisk Vows Pipeline Expansion While Alkermes Targets ADHD Market

By Andrew Joseph · STAT News · 2026-09-21

STAT News reports that Novo Nordisk is pivoting toward a consumer-oriented sales model to sustain its financial momentum through the end of the decade. Meanwhile, early clinical data suggests Alkermes may have found a new use for orexin agonists, traditionally used for sleep diso

STAT News reports that Novo Nordisk is pivoting toward a consumer-oriented sales model to sustain its financial momentum through the end of the decade. Meanwhile, early clinical data suggests Alkermes may have found a new use for orexin agonists, traditionally used for sleep diso